Metrics to compare | 6190 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6190PeersSector | |
|---|---|---|---|---|
P/E Ratio | 84.7x | 13.0x | −0.3x | |
PEG Ratio | 0.82 | 0.06 | 0.00 | |
Price/Book | 0.9x | 1.8x | 2.6x | |
Price / LTM Sales | 0.9x | 2.0x | 2.9x | |
Upside (Analyst Target) | - | 23.3% | 65.2% | |
Fair Value Upside | Unlock | 7.3% | 9.1% | Unlock |
PhoenixBio Co., Ltd. provides contract testing services for pharmaceutical development in Japan, the United States, Europe, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver; and PXB-cells, a human hepatocyte for studies which require the use of primary human hepatocytes, such as drug metabolism, enzyme induction/inhibition, safety assessment, transporter evaluation, anti-HBV therapeutics efficacy testing, and other studies. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. PhoenixBio Co., Ltd. was incorporated in 2002 and is headquartered in Higashihiroshima, Japan.